Needham Reiterates a Buy Rating on Harmony Biosciences (HRMY)
Presented at the SLEEP 2025 conference, the data highlights significant clinical activity in an orexin/ataxin-3 mouse model, with no noted safety concerns and a wide therapeutic index. This is a positive factor for the drug's efficacy, as it points towards the potential for nearly complete wakefulness at low doses.
A close-up of a pharmaceutical drug bottle, showcasing the potential of the company's innovative therapies.
The analyst further supported the optimistic rating for Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) with comparative data from other compounds, such as ORX750 and TAK-861, which demonstrated promising results with considerable wakefulness and a reduction in cataplexy episodes. All these factors contribute to a bullish outlook for the company's pipeline for addressing unmet needs in sleep disorders.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is a commercial-stage pharmaceutical company that develops and commercializes therapies to treat neurological disorders. Its product, WAKIX, is a molecule that increases histamine signaling in the brain by binding to H3 receptors. The company has one of the strongest pipelines for people with rare neurological diseases.
While we acknowledge the potential of HRMY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Cisco Systems Beats Fourth-Quarter Views Amid Demand Momentum
Cisco Systems' (CSCO) fiscal fourth-quarter results surpassed Wall Street's estimates as demand for Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
D-BOX Confirms Naveen Prasad as President and CEO and Announces Leadership Realignment to Accelerate Growth and Execution
MONTREAL, Aug. 13, 2025 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. (TSX: DBO), a global leader in haptic and immersive entertainment technology with systems deployed on well over 1,000 theatrical screens worldwide and a growing leadership position across simulation racing, training, and experiential markets, today announced the appointment of Naveen Prasad as President and Chief Executive Officer, effective immediately. Mr. Prasad, elected to the Board of Directors at the Corporation's annual and special meeting of shareholders held on September 25, 2024, has served as Interim CEO since June 2025. His early tenure has already delivered meaningful momentum through executive realignment, commercial clarity, and improved financial and operational discipline. 'Naveen stepped into the interim role with clarity and conviction,' said Brigitte Bourque, Chair of the Board. 'He has energized the company, aligned the leadership team, and sharpened our focus on performance and market opportunity. We're pleased to confirm him as permanent CEO.' Executive and Structural Changes to Drive Companywide Execution Alongside Mr. Prasad's confirmation, D-BOX has implemented a strategic realignment of its leadership structure to improve execution, streamline decision-making, and accelerate growth across all segments: David Reid has been promoted to Chief Financial Officer, expanding his leadership across financial strategy, public disclosure, and cross-functional performance. Sébastien Boire Lavigne has been elevated to Chief Product and Technology Officer, unifying product, technology, IP and delivery under one mandate. A search is underway for a newly created Chief Commercial Officer role, which will integrate revenue, brand, and market strategy to unlock new growth opportunities and strengthen global positioning. Matt Garelik joins as Strategy & Business Development Consultant, reporting to the CEO. He will advise on commercial acceleration and brings leadership and his industry experience with studios, exhibitors and vendors such as Barco and Nielsen EDI. Robert Desautels, former D-BOX CTO and Chair of the Haptic Industry Forum, returns as IP and Platform Licensing Consultant, reporting to the CPTO. He will support licensing initiatives and technology monetization. In connection with these changes, Joshua Chandler, who previously held the CFO role, has officially left the company effective today. We wish him well in his future endeavours. Together, these changes reflect a focused commitment to operational rigor, commercial innovation, and value creation. 'We've sharpened our leadership structure, strengthened execution, and aligned the company for sustainable growth,' said Mr. Prasad. 'D-BOX is positioned to build deeper industry partnerships, expand market leadership, and deliver long-term value for shareholders.' This announcement coincides with the release of D-BOX's Q1 FY2026 financial results. ABOUT D-BOX TECHNOLOGIES INC. D-BOX Technologies Inc. (TSX: DBO) is a global leader in haptic technology, delivering immersive motion experiences that engage the body and spark the imagination. Our patented systems synchronize motion, vibration, and texture with on-screen content, enhancing storytelling across various platforms. With over 25 years of innovation, D-BOX's solutions are utilized in movie theaters, sim racing, and simulation & training. Headquartered in Montreal, Canada, with offices in Los Angeles, USA, D-BOX continues to redefine how audiences experience media worldwide. Visit FOR FURTHER INFORMATION, PLEASE CONTACT: D-BOX Media Relationsmedia@ D-BOX Investor Relationsinvestors@ DISCLAIMER REGARDING FORWARD-LOOKING STATEMENTSCertain information included in this press release may constitute 'forward-looking information' within the meaning of applicable Canadian securities legislation. Forward-looking information may include, among others, statements regarding the future plans, activities, objectives, operations, strategy, business outlook, and financial performance and condition of the Corporation, or the assumptions underlying any of the foregoing. In this document, words such as 'may', 'would', 'could', 'will', 'likely', 'believe', 'expect', 'anticipate', 'intend', 'plan', 'estimate' and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. Forward-looking information, by its very nature, is subject to numerous risks and uncertainties and is based on several assumptions which give rise to the possibility that actual results could differ materially from the Corporation's expectations expressed in or implied by such forward-looking information and no assurance can be given that any events anticipated by the forward-looking information will transpire or occur, including but not limited to the future plans, activities, objectives, operations, strategy, business outlook and financial performance and condition of the Corporation. Forward-looking information is provided in this press release for the purpose of giving information about Management's current expectations and plans and allowing investors and others to get a better understanding of the Corporation's operating environment. However, readers are cautioned that it may not be appropriate to use such forward-looking information for any other purpose. Forward-looking information provided in this document is based on information available at the date hereof and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond the Corporation's control. The risks, uncertainties and assumptions that could cause actual results to differ materially from the Corporation's expectations expressed in or implied by the forward-looking information include, but are not limited to, the ability to complete a successful senior leadership transition. These and other risk factors that could cause actual results to differ materially from expectations expressed in or implied by the forward-looking information are discussed under 'Risk Factors' in the Corporation's annual information form for the fiscal year ended March 31, 2025, a copy of which is available on SEDAR+ at Except as may be required by Canadian securities laws, the Corporation does not intend nor does it undertake any obligation to update or revise any forward-looking information contained in this press release to reflect subsequent information, events, circumstances or otherwise. The Corporation cautions readers that the risks described above are not the only ones that could have an impact on it. Additional risks and uncertainties not currently known to the Corporation or that the Corporation currently deems to be immaterial may also have a material adverse effect on the Corporation's business, financial condition or results of in to access your portfolio
Yahoo
13 minutes ago
- Yahoo
KBR secures NASA contract worth up to $3.6 billion for astronaut health support
(Reuters) -Engineering contractor KBR said on Wednesday it had secured a $2.46 billion contract from the National Aeronautics and Space Administration to support astronaut and worker health and safety during space missions. Shares of KBR rose 2.7% in extended trading. The five-year agreement, starting November 1, includes two optional extensions potentially extending the contract until 2035. Most work will be conducted at NASA's Johnson Space Center in Houston, Texas. The total estimated value, including the extensions, is $3.6 billion, the company said. The deal extends KBR's partnership with the space agency and underscores its role in spaceflight operations. KBR will provide services such as monitoring crew health, occupational health support and researching risk reduction strategies for astronauts, including those involved in the Artemis program aimed at future Moon missions. "This contract reinforces KBR's leadership in human spaceflight operations," said Mark Kavanaugh, KBR president, defense, intel and space. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
